Home › Vascular Diseases › Pennsylvania › Philadelphia
Vascular Diseases clinical trials in Philadelphia, PA
3 studies for Vascular Diseases are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
Recruiting
- Lankenau Institute for Medical Research, Wynnewood · 7 mi away
Zenith® Fenestrated+ Clinical Study
Recruiting
- Hospital of the University of Pennsylvania, Philadelphia
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
RecruitingObservational study
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University, Philadelphia
About Vascular Diseases
Your vascular system is made up of blood vessels that carry blood to and from the heart. Learn about vascular diseases and their treatments.
More about Vascular Diseases on MedlinePlus
Vascular Diseases trials in other cities
- Boston, MA13 studies
- Washington, DC7 studies
- St. Louis, MO5 studies
- Durham, NC5 studies
- Dallas, TX5 studies
- Atlanta, GA4 studies
- Mountain View, CA4 studies
- Cleveland, OH4 studies
- Los Angeles, CA4 studies
- Tampa, FL4 studies
- Detroit, MI4 studies
- New York City, NY4 studies
Other studies in Philadelphia
- Cancer (all types)57 studies
- Breast Cancer51 studies
- Non-Small Cell Lung Cancer49 studies
- Ovarian Cancer47 studies
- Metastatic Cancer42 studies
- Colorectal Cancer41 studies
- Prostate Cancer41 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia33 studies
- Heart Failure31 studies
- Endometrial Cancer29 studies
- Pancreatic Cancer26 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.